PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is a prospective, randomized, double-blind, single-center clinical trial designed to evaluate the effects of Clostridium butyricum CBM588 supplementation on postoperative diarrhea, gastrointestinal symptoms, and quality of life in patients undergoing pancreaticoduodenectomy for periampullary neoplasms. Oncological outcomes, including disease-free survival and overall survival, will be monitored as secondary endpoints during follow-up.
Epistemonikos ID: bcb48d7a7143f9760cbcbf01c7afbc1f2a7f0355
First added on: Feb 20, 2026